BioVU Archive — Page 8 of 8

July 10, 2014

VU, Celgene announce research partnership

Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market.

By Bill Snyder
June 12, 2014

Roden named to NIH’s genomics advisory council

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH).

By Bill Snyder
March 31, 2014

E-records shed light on drug response

Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response.

By Leigh MacMillan
January 10, 2014

A pain in the … genes

Vanderbilt researchers have discovered that variation in the gene encoding the potassium channel GIRK1 plays a role in modulating human pain perception.

By Leigh MacMillan
November 29, 2012

Symposium highlights VU’s clinical, translational research

Nearly $5 million in internal pilot grants to jumpstart research projects. A tripling in the number of clinical and translational research publications. Novel research tools that have been snapped up by scientists around the world.

By Bill Snyder
September 27, 2012

AAMC meet highlights need for research funds

During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research.

By Bill Snyder